Drug Shortage Report for APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR
| Report ID | 189653 |
| Drug Identification Number | 02468247 |
| Brand name | APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR |
| Common or Proper name | EMTRICITABINE/TENOFOVIR/EFAVIRENZ |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TENOFOVIR DISOPROXIL FUMARATE EMTRICITABINE EFAVIRENZ |
| Strength(s) | 300MG 200MG 600MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 BTL |
| ATC code | J05AR |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-04-11 |
| Estimated end date | 2023-07-07 |
| Actual end date | 2023-07-04 |
| Shortage status | Resolved |
| Updated date | 2023-07-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2023-07-07 | French | Compare |
| v13 | 2023-07-07 | English | Compare |
| v12 | 2023-06-29 | French | Compare |
| v11 | 2023-06-29 | English | Compare |
| v10 | 2023-06-23 | French | Compare |
| v9 | 2023-06-23 | English | Compare |
| v8 | 2023-05-26 | French | Compare |
| v7 | 2023-05-26 | English | Compare |
| v6 | 2023-05-19 | French | Compare |
| v5 | 2023-05-19 | English | Compare |
| v4 | 2023-05-06 | French | Compare |
| v3 | 2023-05-06 | English | Compare |
| v2 | 2023-04-14 | French | Compare |
| v1 | 2023-04-14 | English | Compare |
Showing 1 to 14 of 14